Back to Search
Start Over
Supplementary Table 2 from Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file, 66K, Quantification of proteins from Western blots in Supplementary Figure S7 by densitometry using ImageJ software.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....7a096ca6055776f52be2a6d8eb21ef1d
- Full Text :
- https://doi.org/10.1158/1535-7163.22499185.v1